Combination immunotherapy ups survival in ILD patients with anti-MDA5–positive dermatomyositisDecember 13, 2018Autoimmune DiseasesMedical Dermatology
RELIEF: In Behçet’s, apremilast improves oral ulcers for up to 28 weeksDecember 1, 2018Autoimmune DiseasesRare Diseases
Three drugs disappoint in SSc trials, but show some promiseNovember 27, 2018Medical DermatologyAutoimmune Diseases
ACR CRISS: A way forward for scleroderma treatment trials?November 27, 2018Medical DermatologyAutoimmune Diseases
Short-term lung function better predicts mortality risk in SScNovember 26, 2018Medical DermatologyAutoimmune Diseases
Development of reversible B-cell inhibitor XmAb5871 for SLE moves forwardNovember 19, 2018Autoimmune Diseases
Fear of blindness hobbles hydroxychloroquine treatment of SLENovember 16, 2018Autoimmune DiseasesMedical Dermatology
Tofacitinib impresses in first trial for dermatomyositisNovember 14, 2018Medical DermatologyAutoimmune Diseases
Scleroderma SCOT trial findings hold similar in lung diseaseNovember 14, 2018Medical DermatologyAutoimmune Diseases
Genetic profile flags scleroderma patients with best HSCT responsesNovember 6, 2018Medical DermatologyAutoimmune Diseases
Leflunomide-hydroxychloroquine combo shows promise in primary Sjögren’s pilot studyNovember 1, 2018Medical DermatologyAutoimmune Diseases
SLE low-disease definition receives prospective validationOctober 24, 2018Autoimmune DiseasesMedical Dermatology
Ablation plus transplant for severe scleroderma shows 11-year benefitsOctober 23, 2018Autoimmune Diseases
IgA vasculitis may be more common in adults than assumedSeptember 19, 2018Rare DiseasesMedical DermatologyAutoimmune Diseases
